Clinical Trial Update: Adrenocorticotropic Hormone (ACTH) for Frequently Relapsing and Steroid Dependent Nephrotic Syndrome [Phase 3]

View source ↗

Summary

Phase 3 trial update on ACTH for frequently relapsing and steroid-dependent nephrotic syndrome; results have been posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nephrotic Syndrome

Drugs mentioned

• adrenocorticotropic hormone (ACTH) (adrenocorticotropic hormone)

Snippet

Sponsor: Emory University | Conditions: Nephrotic Syndrome | Phase 3 | Status: COMPLETED | Results posted: 2019-05-10